FundingWatcher
Home / Investors / Post IPO investors / Post IPO investors in New York, United States

Post IPO investors in New York, United States

Updated 16 Nov 2026

Reset

Venture funds

2 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Casdin Capital
Casdin Capital does fundamental research investing in life sciences and healthcare, with recent companies Multiply Labs and Thyme Care.
New York, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 15% 5
2 Colle Capital Partners
Colle Capital is a data focused and opportunistic global technology venture fund, and recently backed Findigs and RADAR.
New York, United States
Commerce, Artificial intelligence Seed, Early stage venture, Late stage venture 12% 3

Table 1. Post IPO investors in New York, United States: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Post IPO investors in New York, United States
One-time CSV
  • 197 firms, 183 with a website
  • 110 firm email addresses
  • 137 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-post-ipo-investors-new-york-united-states.csv197 rows × 15 columns
InvestorTypeLocationEmailPhone
Tiger Global ManagementHedge fundNew York, United States•••@tigerglobal.com212-98•••
BlackRockInvestment bankNew York, United States•••@blackrock.com212-81•••
Morgan StanleyInvestment bankNew York, United States•••@morganstanley.com+1 212•••
InvusPrivate equity firmNew York, United States•••@invus.com+1 (21•••
Casdin CapitalVenture capital firmNew York, United States•••@casdincapital.com+1 212•••
Hearst VenturesCorporate venture armNew York, United States•••@hearst.com(888) •••
New Leaf Venture PartnersVenture capital firmNew York, United States•••@nlvpartners.com646-87•••
ApolloPrivate equity firmNew York, United States•••@apollo.com212-51•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-stage-post-ipo-investors-new-york-united-states-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
OrbiMedW••• P•••Managing Directorp•••@orbimed.comIn the CSV
InvusK••• B•••Managing Directork•••@invus.comIn the CSV
Casdin CapitalB••• C•••Senior Managing Directorb•••@casdincapital.comIn the CSV
New Leaf Venture PartnersV••• L•••Managing Directorv•••@nlvpartners.comIn the CSV
Aisling CapitalE••• A•••Partnere•••@aislingcapital.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

197
Investors
110
With email
137
With phone
24
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Post IPO investors in New York, United States

30 of 197, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Tiger Global Management Hedge fund, Private equity firm New York, United States Fintech, Artificial intelligence Harbinger, Easol, Mach9 27 1,260 724 223 •••@tigerglobal.com 212-98••• In the CSV
2 OrbiMed Private equity firm New York, United States Health care, Biotech Triveni Bio, Windward Bio, Terremoto Biosciences 8 810 276 304 +1 (21••• In the CSV
3 BlackRock Investment bank, Private equity firm New York, United States Artificial intelligence, Fintech Snorkel AI, Deepgram, Groq 16 472 180 180 •••@blackrock.com 212-81••• In the CSV
4 Morgan Stanley Investment bank New York, United States Fintech, Health care Recykal, Daloopa, Vestwell 3 381 121 173 •••@morganstanley.com +1 212••• In the CSV
5 Perceptive Advisors Hedge fund New York, United States Health care, Biotech Bridge to Life, CereVasc, Talkiatry 3 352 116 196 (646) ••• In the CSV
6 JP Morgan Investment bank, Private equity firm New York, United States Fintech, Artificial intelligence Capitolis, Tabby, Socure 9 322 141 107 +1 212••• In the CSV
7 Citi Investment bank New York, United States Fintech, Artificial intelligence Ramp, Capitolis, Qupital 10 312 111 84 (212) ••• In the CSV
8 Invus Private equity firm New York, United States Health care, Biotech Lycia Therapeutics, Triveni Bio 2 300 52 99 •••@invus.com +1 (21••• In the CSV
9 Blackstone Private equity firm New York, United States Fintech, Cybersecurity Pentera, Idrx, Symphony 292 158 109 +1 (21••• In the CSV
10 Casdin Capital Venture capital firm New York, United States Health care, Biotech Multiply Labs, Thyme Care, Cerevance 5 248 36 93 •••@casdincapital.com +1 212••• In the CSV
11 Hearst Ventures Corporate venture arm New York, United States Artificial intelligence, Commerce Loora 1 199 33 57 •••@hearst.com (888) ••• In the CSV
12 New Leaf Venture Partners Venture capital firm New York, United States Health care, Artificial intelligence Arvist, Truveris, Qlaris Bio 197 52 60 •••@nlvpartners.com 646-87••• In the CSV
13 Pfizer Venture Investments Corporate venture arm New York, United States Biotech, Health care FoRx Therapeutics 1 195 51 52 In the CSV
14 Apollo Private equity firm New York, United States Fintech, Health care CAIS, Kashable 2 182 109 78 •••@apollo.com 212-51••• In the CSV
15 Aisling Capital Private equity firm New York, United States 182 31 105 •••@aislingcapital.com (212) ••• In the CSV
16 Goldman Sachs Growth Equity Private equity firm New York, United States Fintech, Cybersecurity New York Shipping Exchange, Limble CMMS, Crux 155 90 61 •••@goldmansachs.org 415568••• In the CSV
17 RTW Investments Hedge fund New York, United States Biotech, Health care Windward Bio, CORXEL Pharmaceuticals 2 142 41 80 •••@rtwfunds.com +1 646••• In the CSV
18 Catalio Capital Management Venture capital firm New York, United States Biotech, Health care Volastra Therapeutics, PinkDx, Clasp Therapeutics 134 32 30 •••@cataliocapital.com (410) ••• In the CSV
19 Third Point Ventures Hedge fund, Venture capital firm New York, United States Cybersecurity, Artificial intelligence Channel Medsystems 1 124 51 39 •••@thirdpoint.com +1 212••• In the CSV
20 The Global Emerging Markets Group Private equity firm New York, United States Artificial intelligence, Hardware KaJ Labs, Spendwisor Inc 123 75 42 •••@gemny.com (212) ••• In the CSV
21 Access Industries Hedge fund, Private equity firm New York, United States Commerce, Artificial intelligence Tripledot Studios, Gett, TAP Network 101 28 35 +1 212••• In the CSV
22 RBC Capital Markets Investment bank Albany, United States Commerce Checkfront, Antarctica Systems, Tacit Knowledge 100 54 63 •••@rbccm.com In the CSV
23 Fortress Investment Group Private equity firm New York, United States Hardware, Fintech Razor Group, Pivotal Commware, AURA Network Systems 99 61 44 •••@fortress.com +1 212••• In the CSV
24 Bienville Capital Hedge fund, Startup incubator New York, United States Fintech, Health care Renterra, August Schools 2 99 15 15 •••@bienvillecapital.com 212-22••• In the CSV
25 Colle Capital Partners Venture capital firm New York, United States Commerce, Artificial intelligence Findigs, RADAR, Qureos 3 97 12 12 •••@collecapital.com +352 3••• In the CSV
26 Blue Owl Private equity firm New York, United States Health care, Biotech Lycia Therapeutics, Windward Bio, Vestwell 4 84 38 33 •••@blueowl.com In the CSV
27 Cowen Healthcare Investments Venture capital firm New York, United States Biotech MBrace Therapeutics 80 19 43 •••@gmail.com +1-646•••
28 D. E. Shaw & Co. Private equity firm New York, United States Cybersecurity, Artificial intelligence ThreatLocker, Backslash Security, Neural Concept 3 74 28 21 •••@deshaw.com +1 212••• In the CSV
29 Feenix Venture Partners Venture debt fund New York, United States Fintech, Health care League Network 73 44 8 •••@feenixpartners.com (646) ••• In the CSV
30 Veronis Suhler Stevenson Private equity firm New York, United States 70 61 29 +1 212••• In the CSV

Table 2. Post IPO investors in New York, United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 197.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Tiger Global Management New York, United States 27 289 Harbinger, Easol, Mach9
2 BlackRock New York, United States 16 56 Snorkel AI, Deepgram, Groq
3 Citi New York, United States 10 48 Ramp, Capitolis, Qupital
4 JP Morgan New York, United States 9 23 Capitolis, Tabby, Socure
5 OrbiMed New York, United States 8 46 Triveni Bio, Windward Bio, Terremoto Biosciences
6 Casdin Capital New York, United States 5 13 Multiply Labs, Thyme Care, Cerevance
7 Moore Strategic Ventures New York, United States 4 14 HiddenLayer, Utilidata, Sierra Space
8 Blue Owl New York, United States 4 9 Lycia Therapeutics, Windward Bio, Vestwell
9 Perceptive Advisors New York, United States 3 11 Bridge to Life, CereVasc, Talkiatry
10 D. E. Shaw & Co. New York, United States 3 9 ThreatLocker, Backslash Security, Neural Concept
11 Morgan Stanley New York, United States 3 31 Recykal, Daloopa, Vestwell
12 Colle Capital Partners New York, United States 3 16 Findigs, RADAR, Qureos
13 Avenue Capital Group New York, United States 2 3 Unrivaled, Cosm
14 Apollo New York, United States 2 7 CAIS, Kashable
15 Invus New York, United States 2 25 Lycia Therapeutics, Triveni Bio

Table 3. Post IPO investors in New York, United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Easol Easol provides software for managing bookings, ticketing, payments, and customer relationships. Commerce London, United Kingdom Series A $20.0M 2026-10-28 $59.6M Tiger Global Management 11 to 50 2017
Mach9 Mach9 builds a geospatial production platform for engineering and construction firms, starting with Digital Surveyor. Artificial intelligence San Francisco, United States Series A $34.5M 2026-10-21 $51.3M Tiger Global Management 11 to 50 2021
Rebill Rebill provides financial infrastructure for businesses and platforms operating across the Americas. Commerce Miami, United States Seed $5.4M 2026-10-20 $9.0M Tiger Global Management 11 to 50 2020
Tenstorrent Unicorn Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. Artificial intelligence Santa Clara, United States Series E $1.5B 2026-10-19 $2.5B Moore Capital 501 to 1,000 2016
Meow Meow offers businesses interest-bearing checking accounts, treasury services, invoicing, and bill pay. Fintech New York, United States Series B $31.6M 2026-10-15 $58.6M Tiger Global Management 11 to 50 2021
ICON Unicorn ICON builds construction technology, including 3D-printed homes and structures, for projects on Earth and beyond. Artificial intelligence Austin, United States Series D $200.0M 2026-10-13 $772.8M Tiger Global Management 251 to 500 2017
Ramp Unicorn Ramp provides software for corporate spend management, finance operations, and business payments. Artificial intelligence New York, United States Series G $1.9B 2026-10-09 $5.6B Citi 1,001 to 5,000 2019
Capitolis Unicorn Capitolis provides technology and financial solutions that improve capital efficiency and reduce capital markets risk. Fintech New York, United States Series E $120.0M 2026-10-06 $557.8M Citi, JP Morgan 51 to 100 2017
Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence San Francisco, United States Series B $75.0M 2026-10-06 $97.7M Casdin Capital 11 to 50 2016
Rightway Unicorn Rightway provides a health technology service that lowers healthcare costs and improves patient outcomes. Health care New York, United States Series E $155.0M 2026-09-24 $394.3M Tiger Global Management 501 to 1,000 2017

Table 4. Post IPO investors in New York, United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 615 71%
Fintech 212 24%
Artificial intelligence 191 22%
Health care 166 19%
Hardware 116 13%
Biotech 103 12%
Commerce 100 11%
Cybersecurity 63 7%
Education 31 4%
Energy 17 2%

Table 5. Post IPO investors in New York, United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Post IPO investors in New York, United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
New York 188 95%
Nyack 2 1%
Albany 1 1%
Florida 1 1%
Alfred 1 1%
Manhasset 1 1%
Spring Valley 1 1%
Manhattan 1 1%
Levittown 1 1%

Table 7. Post IPO investors in New York, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 8 5%
2010s 65 38%
2000s 33 19%
1990s 29 17%
1980s 19 11%
1970s 5 3%

Table 8. Post IPO investors in New York, United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many post ipo investors in New York, United States are on the list?
197, in the file dated 16 November 2026. 24 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
110 of the 197 carry an email address in the download and 137 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 197 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 197 rows, 110 firm email addresses and 137 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 80 of the 110 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Post IPO investors in New York, United States: 197 rows, CSV, $29 one-time.

At once: the CSV with 197 rows, 110 firm email addresses and 137 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 80 of the 110 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Post IPO investors by city in New York

Investor types in New York

Other stages in New York

Post IPO investors elsewhere

Cite: FundingWatcher, 197 post ipo investors in New York, United States, 16 November 2026. https://fundingwatcher.com/investors/stage/post-ipo-investors/new-york-united-states/